Organization: Stressgen Bioreagents Corp

Stressgen sells reagents business, withdraws offering

Victoria-based Stressgen Biotechnologies Corp has withdrawn its proposed common shares offering, sold off its bioreagents business and replaced its president and CEO. The reagents business was sold for $8 million to the newly formed Stressgen Bioreagents Corp funded by Ampersand Ventures. Accompanying the sale are 26 of the firm’s 103 employees. The withdrawal of the…